PH22526A - 2-2' bi-ih-imidazoles - Google Patents

2-2' bi-ih-imidazoles

Info

Publication number
PH22526A
PH22526A PH34501A PH34501A PH22526A PH 22526 A PH22526 A PH 22526A PH 34501 A PH34501 A PH 34501A PH 34501 A PH34501 A PH 34501A PH 22526 A PH22526 A PH 22526A
Authority
PH
Philippines
Prior art keywords
imidazoles
Prior art date
Application number
PH34501A
Other languages
English (en)
Inventor
Donald P Matthews
James R Mccarthy
Jeffrey P Whitten
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of PH22526A publication Critical patent/PH22526A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH34501A 1985-11-25 1986-11-20 2-2' bi-ih-imidazoles PH22526A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80145885A 1985-11-25 1985-11-25

Publications (1)

Publication Number Publication Date
PH22526A true PH22526A (en) 1988-10-17

Family

ID=25181154

Family Applications (1)

Application Number Title Priority Date Filing Date
PH34501A PH22526A (en) 1985-11-25 1986-11-20 2-2' bi-ih-imidazoles

Country Status (19)

Country Link
EP (1) EP0229922B1 (fi)
JP (1) JPS62135461A (fi)
KR (1) KR900000671B1 (fi)
CN (1) CN86108027A (fi)
AT (1) ATE74912T1 (fi)
AU (1) AU585409B2 (fi)
CA (1) CA1286301C (fi)
DE (1) DE3684900D1 (fi)
DK (1) DK562686A (fi)
ES (1) ES2036520T3 (fi)
FI (1) FI864751A (fi)
GR (1) GR3004386T3 (fi)
HU (1) HU205087B (fi)
IL (1) IL80733A0 (fi)
NO (1) NO167801C (fi)
NZ (1) NZ218354A (fi)
PH (1) PH22526A (fi)
PT (1) PT83799B (fi)
ZA (1) ZA868809B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839375A (en) * 1987-07-28 1989-06-13 Merrell Dow Pharmaceuticals Inc. (Aryl or heteroaromatic methyl)-2,2'-bi-1H-imidazoles and their use as anti-hypertensive agents
US7322704B2 (en) 2004-07-30 2008-01-29 Novalux, Inc. Frequency stabilized vertical extended cavity surface emitting lasers
JP4935090B2 (ja) * 2006-01-31 2012-05-23 ソニー株式会社 半導体発光装置
CN101676293B (zh) * 2008-09-18 2012-11-21 宁波大学 一种联咪唑有机膦化合物及其制备方法
CN102304089A (zh) * 2011-07-01 2012-01-04 中国科学院过程工程研究所 一种4,4′,5,5′-四硝基-2,2′-联咪唑的合成方法

Also Published As

Publication number Publication date
NO167801C (no) 1991-12-11
KR870004977A (ko) 1987-06-02
HUT42075A (en) 1987-06-29
AU6556586A (en) 1987-05-28
EP0229922A3 (en) 1988-03-30
DK562686D0 (da) 1986-11-24
PT83799A (en) 1986-12-01
DE3684900D1 (de) 1992-05-21
ZA868809B (en) 1987-07-29
ES2036520T3 (es) 1993-06-01
FI864751A0 (fi) 1986-11-21
NO864695D0 (no) 1986-11-24
DK562686A (da) 1987-05-26
PT83799B (pt) 1988-08-17
FI864751A (fi) 1987-05-26
IL80733A0 (en) 1987-02-27
KR900000671B1 (ko) 1990-02-02
JPS62135461A (ja) 1987-06-18
EP0229922A2 (en) 1987-07-29
GR3004386T3 (fi) 1993-03-31
NZ218354A (en) 1989-09-27
AU585409B2 (en) 1989-06-15
ATE74912T1 (de) 1992-05-15
NO167801B (no) 1991-09-02
CN86108027A (zh) 1987-10-07
CA1286301C (en) 1991-07-16
HU205087B (en) 1992-03-30
EP0229922B1 (en) 1992-04-15

Similar Documents

Publication Publication Date Title
GB2209202B (en) "heater"
GB8615140D0 (en) 5 6-epoxy-7-oxabicycloheptane
GB8615141D0 (en) 5 6-epoxy-7-oxabicycloheptane
CS843186A2 (en) Zpusob vyroby karbapenemovych derivatu nesoucich v poloze 2 kvarternizovany heterothioalkylthiosubstituent
PH22526A (en) 2-2' bi-ih-imidazoles
GB8521293D0 (en) 2 2 6 6-eteramethylpiperidylamides
CS715586A2 (en) Zpusob vyroby novych 2 substituovanych derivatu ergolinu
CS440685A1 (en) Zpusob vyroby 2 merkaptoethansulfonove kyseliny
GB8612109D0 (en) 2 4-dichloro-5-nitrothiazole
GB2152933B (en) Novel n-phosphoryl- or n-thiophosphoryl-n'-s-triazinyl-formamidines
GB8500263D0 (en) 4'-deoxy-4'-halodoxorubicin-14-esters
CS562185A1 (en) Zpusob pripravy chlorovanych 2 chlormetansulfonylaminodifenyleteru
GB8500261D0 (en) 4'-epidoxorubicin-14-esters
GB8500262D0 (en) 4'-deoxydoxorubicin-14-esters
CS305186A2 (en) Zpusob vyroby substituovanych 4 benzylpiperazinylderivatu
CS840385A1 (en) Sposob vyroby modifikovaneho 2 merkaptobenztiazolu
CS815785A2 (en) Zpusob vyroby 3 substituovanych 2 oxindolu
CS604185A1 (en) Sposob vyroby 2 alkoxypropenov
CS240685A1 (en) 020485
CS49985A1 (en) Sposob pripravy vodnych roztokov 3 metakryloxypropylsilanolov
CS131085A1 (en) Zpusob pripravy 3 fluorthiofenolu
CS131185A1 (en) Zpusob pripravy 3 fluornitrobenzenu
CS13885A1 (en) 070185
CS230585A1 (en) Zpusob pripravy technickeho 4 sulfoftaliminu amonneho
CS11585A1 (en) Zpusob cisteni 2 aminonaftalen l sulfonove kyseliny